Wang Jie, Liu Sha, Pan Tao, Wang Mingkun, Li Liang, Weng Xiangqian, Jia Panhong, Li Qi, Zhou Xiangdong
Nanjing Medical University, Nanjing, China.
Department of Respiratory Diseases, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
Transl Cancer Res. 2021 Sep;10(9):4116-4124. doi: 10.21037/tcr-21-1499.
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors. The prognosis of patients with advanced NSCLC is poor due to metastasis. In recent years, the role of long non-coding RNAs (lncRNAs), a class of non-coding RNA molecules, in NSCLC has become an increasingly popular focus of studies. This study aimed to investigate the effects of ZNF674-AS1 and microRNA (miR)-23a on the migration and invasion abilities of NSCLC cells and explore the underpinning molecular mechanisms.
The expression levels of ZNF674-AS1 and miR-23a in NSCLC tissues and cells were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Scratch test and transwell test were used to detect the effects of ZNF674-AS1 and miR-23a on the migration and invasion of NSCLC cells. The luciferase reporter gene experiment was used to verify miRNA targets. Western blot experiments were used to analyze protein expression.
ZNF674-AS1 was downregulated in NSCLC tissues and cells, and inhibited the migration and invasion of NSCLC cells . In contrast, the expression of miR-23a, a downstream target of ZNF674-AS1, was increased in NSCLC tissues and cells. We found that miR-23a could antagonize the role of ZNF674-AS1 in NSCLC. E-cadherin was identified as a downstream target gene of miR-23a, and miR-23a could directly inhibit its expression.
ZNF674-AS1 inhibits the migration and invasion of NSCLC cells by regulating a miR-23a/E-cadherin axis. ZNF674-AS1 and miR-23a could become potential therapeutic targets for NSCLC.
非小细胞肺癌(NSCLC)是最常见的恶性肿瘤之一。晚期NSCLC患者由于转移,预后较差。近年来,一类非编码RNA分子——长链非编码RNA(lncRNAs)在NSCLC中的作用已成为越来越热门的研究焦点。本研究旨在探讨ZNF674-AS1和微小RNA(miR)-23a对NSCLC细胞迁移和侵袭能力的影响,并探索其潜在的分子机制。
采用定量实时聚合酶链反应(qRT-PCR)检测NSCLC组织和细胞中ZNF674-AS1和miR-23a的表达水平。划痕试验和Transwell试验用于检测ZNF674-AS1和miR-23a对NSCLC细胞迁移和侵袭的影响。荧光素酶报告基因实验用于验证miRNA靶点。蛋白质印迹实验用于分析蛋白质表达。
ZNF674-AS1在NSCLC组织和细胞中表达下调,并抑制NSCLC细胞的迁移和侵袭。相反,作为ZNF674-AS1下游靶点的miR-23a在NSCLC组织和细胞中的表达增加。我们发现miR-23a可拮抗ZNF674-AS1在NSCLC中的作用。E-钙黏蛋白被鉴定为miR-23a的下游靶基因,miR-23a可直接抑制其表达。
ZNF674-AS1通过调节miR-23a/E-钙黏蛋白轴抑制NSCLC细胞的迁移和侵袭。ZNF674-AS1和miR-23a可能成为NSCLC的潜在治疗靶点。